The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim for tests on humans within four years.
Danish scientists from the University of Copenhagen and the University of British Columbia (UBC) face a possible breakthrough in the fight against cancer, which may result in a genuine medical treatment for the dreaded disease.
The hunt for a weapon to fight malaria in pregnant women has revealed that, expressed in popular terms, armed malaria proteins can kill cancer. The researchers behind the discovery hope to be able to conduct tests on humans within four years.
In collaboration with cancer researcher Mads Daugaard from the University of British Columbia in Canada, malaria researcher Professor Ali Salanti from the Faculty of Medical Health and Sciences, UCPH, has revealed that the carbohydrate that the malaria parasite attaches itself to in the placenta in pregnant women is identical to a carbohydrate found in cancer cells.
In the laboratory, scientists have created the protein that the malaria parasite uses to adhere to the placenta and added a toxin. This combination of malaria protein and toxin seeks out the cancer cells, is absorbed, the toxin released inside, and then the cancer cells die. This process has been witnessed in cell cultures and in mice with cancer. The discovery has only just been described in an article in the renowned scientific journal Cancer Cell.
“For decades, scientists have been searching for similarities between the growth of a placenta and a tumor. The placenta is an organ, which within a few months grows from only few cells into an organ weighing approx. two pounds, and it provides the embryo with oxygen and nourishment in a relatively foreign environment. In a manner of speaking, tumors do much the same, they grow aggressively in a relatively foreign environment,” says Ali Salanti from the Department of Immunology and Microbiology at the University of Copenhagen.
Ali Salanti’s team is currently testing a vaccine against malaria on humans, and it was in connection with the development of this drug that he discovered that the carbohydrate in the placenta was also present in cancer tumors. Ali Salanti immediately contacted his former fellow student and now cancer researcher, Mads Daugaard, who is head of the Laboratory of Molecular Pathology at the Vancouver Prostate Center at UBC in Canada. In collaboration, the two groups have generated results, which they hope will provide the basis for a drug against cancer.
“We examined the carbohydrate’s function. In the placenta, it helps ensure fast growth. Our experiments showed that it was the same in cancer tumors. We combined the malaria parasite with cancer cells and the parasite reacted to the cancer cells as if they were a placenta and attached itself,” Ali Salanti explains.
The Latest on: Cure for cancer
via Google News
The Latest on: Cure for cancer
- Recent-Onset Diabetes, Weight Loss Tied to Cancer in 30-Year Studyon August 13, 2020 at 1:36 pm
Individuals with recent-onset diabetes accompanied by weight loss had a high risk for pancreatic cancer and could be a group that would benefit from surveillance, scientists said. In a cohort of ...
- Communities Nationwide Remain Laser-Focused on Helping Cancer Patients Who Can't Wait For Pandemic to Go Awayon August 13, 2020 at 11:49 am
Focused on Helping Cancer Patients Who Can't Wait For Pandemic to Go AwayPR NewswireRYE BROOK, N. 13, 2020The Leukemia & Lymphoma Society Announces Winners of 2020 Man & Woman of the Year Fundraising ...
- Two Wins in GI Cancer; Bolder Actions for Disparities; Support for Earlier Mammoon August 13, 2020 at 11:40 am
Bristol Myers Squibb announced positive results from two trials in gastric and esophageal cancer: Nivolumab (Opdivo) plus chemotherapy improved progression-free survival (PFS) as initial treatment for ...
- People waiting for hospital treatment in England at highest level everon August 13, 2020 at 4:53 am
Low cancer referral figures also suggest backlog of undiagnosed cases, say experts ...
- Breast cancer 'ecosystem' reveals possible new targets for treatmenton August 13, 2020 at 3:02 am
Garvan researchers have used cellular genomics to uncover promising therapy targets for triple negative breast cancer.
- Targeted treatments help reduce death rates for most common lung cancer, study findson August 13, 2020 at 2:37 am
Mortality rates for the most common type of lung cancer -- non-small cell lung caner -- have fallen significantly in recent years as a result of new treatments, according to a study by the National ...
- Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast canceron August 13, 2020 at 2:25 am
Axillary management after NET has not been well studied and the significance of residual axillary node disease after NET remains uncertain. We used the National Cancer Data Base to examine the ...
- Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort studyon August 13, 2020 at 2:22 am
Approximately 268,600 women were diagnosed with invasive breast cancer in the United States in 2019 1. Breast cancer is rapidly becoming more common in other parts of the world 2. In the past 40 years ...
- 'There's no cure for this' | Tampa dad diagnosed with an aggressive type of brain canceron August 12, 2020 at 8:34 pm
His family says it is the same type of brain cancer that John McCain had battled. Don's family is now looking to stay positive and "think of the best quality of life and the best treatment options." ...
- 'There is hope’: Sharp decline in lung cancer mortality linked to advanced treatments, study sayson August 12, 2020 at 2:17 pm
Lung cancer is the leading cause of cancer-related deaths in the United States. But advances in treatment should give patients hope, study says.
via Bing News